Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Islet α cells and glucagon—critical regulators of energy homeostasis
Jonathan E. Campbell, Daniel J. Drucker
Nature Reviews Endocrinology (2015) Vol. 11, Iss. 6, pp. 329-338
Closed Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
Hiddo J.L. Heerspink, Bruce A. Perkins, David Fitchett, et al.
Circulation (2016) Vol. 134, Iss. 10, pp. 752-772
Open Access | Times Cited: 1082
Metabolism disrupting chemicals and metabolic disorders
Jerrold J. Heindel, Bruce Blumberg, Mathew C. Cave, et al.
Reproductive Toxicology (2016) Vol. 68, pp. 3-33
Open Access | Times Cited: 933
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen, Jesper Lau
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 641
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Chase Romere, Clemens Duerrschmid, Juan C. Bournat, et al.
Cell (2016) Vol. 165, Iss. 3, pp. 566-579
Open Access | Times Cited: 462
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus
Abd A. Tahrani, Anthony Barnett, Clifford J. Bailey
Nature Reviews Endocrinology (2016) Vol. 12, Iss. 10, pp. 566-592
Open Access | Times Cited: 353
Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism
Eun Roh, Do Kyeong Song, Min-Seon Kim
Experimental & Molecular Medicine (2016) Vol. 48, Iss. 3, pp. e216-e216
Open Access | Times Cited: 336
The New Biology and Pharmacology of Glucagon
Timo D. Müller, Brian Finan, Christoffer Clemmensen, et al.
Physiological Reviews (2017) Vol. 97, Iss. 2, pp. 721-766
Closed Access | Times Cited: 334
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans
Amir Tirosh, Ediz S. Calay, Gürol Tuncman, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 489
Open Access | Times Cited: 237
Unimolecular Polypharmacy for Treatment of Diabetes and Obesity
Matthias H. Tschöp, Brian Finan, Christoffer Clemmensen, et al.
Cell Metabolism (2016) Vol. 24, Iss. 1, pp. 51-62
Open Access | Times Cited: 217
β Cell tone is defined by proglucagon peptides through cAMP signaling
Megan E. Capozzi, Berit Svendsen, Sara E. Encisco, et al.
JCI Insight (2019) Vol. 4, Iss. 5
Open Access | Times Cited: 217
Interrupted Glucagon Signaling Reveals Hepatic α Cell Axis and Role for L-Glutamine in α Cell Proliferation
E. Danielle Dean, Mingyu Li, Nripesh Prasad, et al.
Cell Metabolism (2017) Vol. 25, Iss. 6, pp. 1362-1373.e5
Open Access | Times Cited: 183
Glucagon Receptor Signaling and Glucagon Resistance
Lina Janah, Sasha A. S. Kjeldsen, Katrine D. Galsgaard, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3314-3314
Open Access | Times Cited: 160
Tissue-Specific Effects of Leptin on Glucose and Lipid Metabolism
Sandra Pereira, Daemon L. Cline, Maria M. Glavas, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 1, pp. 1-28
Open Access | Times Cited: 150
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives
Riccardo Nevola, Raffaella Epifani, Simona Imbriani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1703-1703
Open Access | Times Cited: 134
Microengineered Multi‐Organoid System from hiPSCs to Recapitulate Human Liver‐Islet Axis in Normal and Type 2 Diabetes
Tingting Tao, Pengwei Deng, Yaqing Wang, et al.
Advanced Science (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 114
Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors
Fenghui Zhao, Qingtong Zhou, Zhaotong Cong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 97
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics
Ania M. Jastreboff, Robert F. Kushner
Annual Review of Medicine (2023) Vol. 74, Iss. 1, pp. 125-139
Open Access | Times Cited: 88
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreaticβ-Cell Function and Diabetes
Matthew J. Varney, Jeffrey Benovic
Pharmacological Reviews (2024) Vol. 76, Iss. 2, pp. 267-299
Open Access | Times Cited: 21
Islet hormones at the intersection of glucose and amino acid metabolism
Phillip J. White, Nicolai J. Wewer Albrechtsen, Jonathan E. Campbell
Nature Reviews Endocrinology (2025)
Closed Access | Times Cited: 2
Evidence of Extrapancreatic Glucagon Secretion in Man
Asger Lund, Jonatan I. Bagger, Nicolai J. Wewer Albrechtsen, et al.
Diabetes (2015) Vol. 65, Iss. 3, pp. 585-597
Open Access | Times Cited: 157
Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial
Yoriko Heianza, Dianjianyi Sun, Xiang Li, et al.
Gut (2018) Vol. 68, Iss. 2, pp. 263-270
Open Access | Times Cited: 147
Glucagon lowers glycemia when β cells are active
Megan E. Capozzi, Jacob B. Wait, Jepchumba Koech, et al.
JCI Insight (2019) Vol. 4, Iss. 16
Open Access | Times Cited: 138
The Liver–α-Cell Axis and Type 2 Diabetes
Nicolai J. Wewer Albrechtsen, Jens Pedersen, Katrine D. Galsgaard, et al.
Endocrine Reviews (2019) Vol. 40, Iss. 5, pp. 1353-1366
Open Access | Times Cited: 134
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions
Shaoyong Lu, Jian Zhang
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 24-45
Closed Access | Times Cited: 130
Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
Megan E. Capozzi, Richard D. DiMarchi, Matthias H. Tschöp, et al.
Endocrine Reviews (2018) Vol. 39, Iss. 5, pp. 719-738
Open Access | Times Cited: 127
Page 1 - Next Page

Scroll to top